Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Prospective memory, emotional valence, and multiple sclerosis.
Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study.
The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study.
Motor skill learning requires active central myelination.
Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab.
First proof for rituximab in IgG4-related disease
Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Predictive value of early brain atrophy on response in patients treated with interferon β.
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Bruxism and temporal bone hypermobility in patients with multiple sclerosis.
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Remyelination therapy goes to trial for multiple sclerosis
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
Drak2 Does Not Regulate TGF-β Signaling in T Cells.
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
Vitamin D intake and incidence of multiple sclerosis.
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.
Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.

Pages